I think the UK MHRA could, or may already have, responded to Cytodyns request for fast track approval.

It is possible that there is now an intricate dance between Cytodyn, FDA and OWS entities against which U.K. actions need to be balanced.

Someone here (sorry I forgot who) posted that Cytodyn has four days to respond material events. I anticipate press release(s) Monday.

I may be wildly wrong, but those are my calculations based on my limited appreciation of the regulatory frameworks involved.